Correspondence re: K. Neben et al., High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin. Cancer Res., 7: 2675-2681, 2001 (multiple letters)

Ronald S. Go; Andrew L. Horstman; Kai Neben; Hartmut Goldschmidt

Correspondence re: K. Neben et al., High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin. Cancer Res., 7: 2675-2681, 2001 (multiple letters)

Ronald S. Go, Andrew L. Horstman, Kai Neben, Hartmut Goldschmidt

Hematology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2750-2751
Number of pages	2
Journal	Clinical Cancer Research
Volume	8
Issue number	8
State	Published - Jan 1 2002

ASJC Scopus subject areas

Oncology
Cancer Research

Cite this

Correspondence re : K. Neben et al., High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin. Cancer Res., 7: 2675-2681, 2001 (multiple letters). / Go, Ronald S.; Horstman, Andrew L.; Neben, Kai et al.

In: Clinical Cancer Research, Vol. 8, No. 8, 01.01.2002, p. 2750-2751.

Research output: Contribution to journal › Letter › peer-review

@article{6ba9990439ec4acfb3f8900eb4607bb1,

title = "Correspondence re: K. Neben et al., High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin. Cancer Res., 7: 2675-2681, 2001 (multiple letters)",

author = "Go, {Ronald S.} and Horstman, {Andrew L.} and Kai Neben and Hartmut Goldschmidt",

year = "2002",

month = jan,

day = "1",

language = "English (US)",

volume = "8",

pages = "2750--2751",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "8",

}

TY - JOUR

T1 - Correspondence re

T2 - K. Neben et al., High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin. Cancer Res., 7: 2675-2681, 2001 (multiple letters)

AU - Go, Ronald S.

AU - Horstman, Andrew L.

AU - Neben, Kai

AU - Goldschmidt, Hartmut

PY - 2002/1/1

Y1 - 2002/1/1

UR - http://www.scopus.com/inward/record.url?scp=0036340693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036340693&partnerID=8YFLogxK

M3 - Letter

C2 - 12171909

AN - SCOPUS:0036340693

VL - 8

SP - 2750

EP - 2751

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 8

ER -

Correspondence re: K. Neben et al., High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin. Cancer Res., 7: 2675-2681, 2001 (multiple letters)

ASJC Scopus subject areas

Other files and links

Cite this